Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease - Wikidata - awgldk - TriplyDB

Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease

Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease

http://www.wikidata.org/entity/Q34804346

about

PPARG binding landscapes in macrophages suggest a genome-wide contribution of PU.1 to divergent PPARG binding in human and mouse Homeodomain transcription factor CDX1 is required for the transcriptional induction of PPARgamma in intestinal cell differentiation Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention The human intestinal microbiome: a new frontier of human biology New insights into the role of fatty acids in the pathogenesis and resolution of inflammatory bowel disease The Mediterranean diet: effects on proteins that mediate fatty acid metabolism in the colon Dextran sodium sulphate colitis mouse model: traps and tricks Therapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Adipokines and the role of visceral adipose tissue in inflammatory bowel disease Saccharomyces cerevisiae modulates immune gene expressions and inhibits ETEC-mediated ERK1/2 and p38 signaling pathways in intestinal epithelial cells PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.The role of peroxisome proliferator-activated receptor γ in immune responses to enteroaggregative Escherichia coli infection.Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ Immunoregulatory actions of epithelial cell PPAR gamma at the colonic mucosa of mice with experimental inflammatory bowel disease.The role of T cell PPAR gamma in mice with experimental inflammatory bowel disease.Dynamic microbe and molecule networks in a mouse model of colitis-associated colorectal cancer.Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice.The PXR is a drug target for chronic inflammatory liver disease.PPARα-dependent exacerbation of experimental colitis by the hypolipidemic drug fenofibrate.CSF-1 receptor-dependent colon development, homeostasis and inflammatory stress response.Immunoregulatory mechanisms of macrophage PPAR-γ in mice with experimental inflammatory bowel disease.PPARs are a unique set of fatty acid regulated transcription factors controlling both lipid metabolism and inflammation Probiotics, nuclear receptor signaling, and anti-inflammatory pathways.Protection by enteral glutamine is mediated by intestinal epithelial cell peroxisome proliferator-activated receptor-γ during intestinal ischemia/reperfusion.Deletion of PPAR-γ in immune cells enhances susceptibility to antiglomerular basement membrane disease Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis Expression of peroxisome proliferator-activated receptor-gamma in macrophage suppresses experimentally induced colitis.Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease.The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis.PPARgamma in human and mouse physiology Bioactive food components, inflammatory targets, and cancer prevention.Significance of anti-inflammatory effects of PPARgamma agonists?Polyphenols in the treatment of inflammatory bowel disease and acute pancreatitis Metabolic control of the Treg/Th17 axis Disruption of inducible 6-phosphofructo-2-kinase impairs the suppressive effect of PPARγ activation on diet-induced intestine inflammatory response.NF-kappa B as a therapeutic target in autoimmune disease.Hepatocyte nuclear factor 4alpha in the intestinal epithelial cells protects against inflammatory bowel disease Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors

P2860

Q21133922-BFF2D419-42A5-44BA-A1FC-4B500EEC34F1 Q24322047-C0E2B313-DDC6-45F8-8D0A-21CB97720895 Q24322799-5666AE74-9B13-4D12-A3C1-DC94B31D345B Q24601222-4C9B1CD4-256E-4E10-A520-39899A382F66 Q24649671-06F474B6-3B2B-4FFB-B3B5-680778E87327 Q26851490-278A24EF-1094-47B4-9DFB-26B5DFA8E2B3 Q26992027-0755C800-72E3-47EE-8BEC-702D95A52D9A Q27001084-096CF57D-EB16-40D0-B83D-DC16119956E0 Q27687166-7598D931-23E7-4DD8-B3B9-260CBE40513E Q28070229-E23CA22B-BB7D-4CC7-B818-5E6F1C481253 Q28741411-EC261116-304E-4FD6-85D4-69D2118DC8D4 Q30006155-D5A8B3B2-1D70-4EB8-A388-34C215D57D9D Q30422017-9A4CC396-A6B5-4634-B16B-9DC5D7C581CB Q30440147-AF57583F-9534-4C56-ACAC-BD1C4006C608 Q30538765-38073961-95AF-409F-87C2-041EC1637EA8 Q33565689-C98F5350-EB8F-4C39-B417-29C6BDDE2135 Q33600282-3B2FBC87-C942-4B22-B8E9-E0E220F56827 Q33613855-0F297BAF-914E-4463-BBAE-DB5D802D0696 Q33712428-A187F1E9-7B9B-4190-A8F9-EE5E9C7BF8CF Q34118368-0465851D-59C4-4CB0-AD85-86C6FF0B356E Q34131110-E4569689-FB3C-42F3-A7EE-2C8D01A553CC Q34602776-8722B087-230C-48DB-AACA-7B283C34F3D6 Q34626425-D4C916F2-17A0-4D98-BBCE-B0F234A9EA04 Q35053566-629941C0-5B05-43E3-9710-A5379956E403 Q35131051-CE6FC8F9-1A85-41A6-AA0B-B368D3A6B8AC Q35177515-56A5EBED-F455-4C6A-A621-ACA92E56B28D Q35557407-4B58A4A8-8C2F-46DF-96B6-627D58B3FAA7 Q35569874-4F351237-4E04-4DBF-A4EA-2513D0EBF21F Q35633338-83A35348-85F9-4DC5-8213-86FFB45CA738 Q35791848-BDD02CB8-7EDC-4031-B53E-0D1A77E65F03 Q35884294-E9D5424E-18C5-439C-A543-378E5A463434 Q36063081-B008C60F-D3E4-4BFE-B277-82CAA5DE820E Q36254183-E921EB64-0FEB-4EE0-878F-FB3831C6CF44 Q36540016-CC9EBA50-BF1C-4FE2-9D3E-C343FD541A99 Q36576621-78508506-FEE0-436D-B3C5-F0A0A6C8D612 Q36622931-A8AF18A4-D803-4B98-BE9A-963AD5FB81F6 Q36644432-7B5E559B-4CA2-466D-9046-42990540BAC9 Q36709522-7DD65715-139A-49EB-982D-942825D6F3C4 Q36732009-5A1762AD-C142-4E26-B4DD-532067C7B2F9 Q36733873-DE8E14C0-650C-45C2-AB76-F9389D23C26D

P2860

Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel disease

http://www.wikidata.org/entity/Q34804346

description

2006 nî lūn-bûn

@nan

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@ast

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@en

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@nl

type

label

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@ast

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@en

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@nl

prefLabel

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@ast

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@en

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@nl

P1433

Q34804346-A6694B33-DE26-4CC4-97D9-21B0CAEC3140

P1476

Q34804346-A8F57D82-260E-4048-B5BF-7D6DD4E9E405

P2093

Q34804346-009D3AC9-34EB-48D7-90C2-282AF7E1FEF1

Q34804346-66149E83-5EAD-4793-B255-8AC78E1BC74C

Q34804346-6FE82E92-13CC-45A1-B3A3-5B10496CAFAC

Q34804346-9E7E0EB8-AF06-423E-8D5D-1B6F3DE2EEEF

Q34804346-A0297FF9-A66D-4777-9514-65C8D0DE377C

Q34804346-AA4F0989-9FFB-4938-B7F6-863ACCFC8BDF

Q34804346-AC1860C5-E1FF-4C2E-BF11-5C1CFF7AF10B

Q34804346-B1D3579F-6AAB-43F5-9D6A-B8D56ABDE677

Q34804346-B8742A42-319D-4BC7-82B8-CF7B0B903C30

Q34804346-C8C3D0A7-88A0-4A0C-A4AB-047CEED64303

P2860

Q34804346-093B7616-D9D1-428C-94B9-734EC12EDBB2

Q34804346-10516038-F2B1-4F56-A15C-3DC25AB74DE8

Q34804346-183A7149-206D-44A1-A0DF-9BC350945D21

Q34804346-1CAF937F-41A5-4067-977B-1A62674D6A1C

Q34804346-1F86DD5C-8057-48DB-97F2-4FFA63C2FBFD

Q34804346-2180EF78-34CA-491E-8186-BD334CB3E884

Q34804346-21CB631B-330D-47A1-8679-40F0915B1A7A

Q34804346-24E02138-453F-4CD7-B331-337FE1250341

Q34804346-2C47B94C-3A53-45B9-B4C8-E300E13D8C4B

Q34804346-2D990FED-A71B-4B47-A44B-321247513B9C

P304

Q34804346-8D6882DC-A602-47D6-99D6-E051E8FE25D2

P31

Q34804346-154A111F-42B0-4A50-A4D0-71695AFB0A09

P356

Q34804346-D0A5ECCF-4758-4923-80C6-EEFBAD8D2BCF

P407

Q34804346-B297AF9E-E7FA-40CB-B9F5-95D74FD5C7F2

P433

Q34804346-910F315A-046B-4F15-BD00-AD82F737962D

P478

Q34804346-99E3B58C-830F-4F1E-8C74-336CE30F42D8

P577

Q34804346-C24D288C-2074-4931-AC0B-D845B7BF2517

P5875

Q34804346-B96FD711-3A0B-4B4C-896A-39DB5ABBE39E

P698

Q34804346-9BB6E5CA-D140-4249-969A-23AA765C11A2

P921

Q34804346-BCBBB991-DCA6-49EA-BC2F-036CBCC66892

Q34804346-CE43513E-CD69-47F1-8566-2C32FB74F54F

P932

Q34804346-2690F7AC-7879-4E1D-ABF1-53EEAAD1EDEA

P356

GUT.2005.081745

P1433

P1476

Peroxisome proliferator activa ...... tal inflammatory bowel disease

@en

P2093

B B Madison

http://www.w3.org/2001/XMLSchema#string

D L Gumucio

http://www.w3.org/2001/XMLSchema#string

F J Gonzalez

http://www.w3.org/2001/XMLSchema#string

H A Young

http://www.w3.org/2001/XMLSchema#string

H E Marin

http://www.w3.org/2001/XMLSchema#string

J M Peters

http://www.w3.org/2001/XMLSchema#string

K Morimura

http://www.w3.org/2001/XMLSchema#string

M Adachi

http://www.w3.org/2001/XMLSchema#string

M Sanford

http://www.w3.org/2001/XMLSchema#string

R Kurotani

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammatory Bowel Disease

The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro

APC-dependent suppression of colon carcinogenesis by PPARgamma

Hic-5 regulates an epithelial program mediated by PPARgamma

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

PPARs and the complex journey to obesity

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

P304

1104-1113

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/GUT.2005.081745

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2006-03-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7231992

http://www.w3.org/2001/XMLSchema#string

P698

16547072

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

1513267

http://www.w3.org/2001/XMLSchema#string